Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Venon, A"'
Autor:
Pietro Andreone, Silvia Aspite, Claudia Campani, Francesco Vizzutti, Fabio Marra, Pasquale Apolito, Sinan Sadalla, Filippo Schepis, A. Scuteri, Laura Turco, Stefano Gitto, Fabio Conti, Giacomo Laffi, Federica Lombardo, Umberto Arena, Giovanni Vitale, Erica Villa, Fabrizio Fanelli, W. Debernardi-Venon
Publikováno v:
Digestive and Liver Disease. 51:870-874
Background Transjugular Intrahepatic Portosystemic Shunt (TIPS) is a well-established treatment for complications of portal hypertension. Aims To analyze the impact of TIPS on virologic response and safety profile in patients treated with direct-acti
Autor:
Antoni M. de Lacy, Annalisa Berzigotti, Josep Fuster, Juan G. Abraldes, Enric Reverter, Annabel Blasi, W. Debernardi-Venon, Agustín Albillos, Jaume Bosch, Javier Martínez, Graciela Martínez-Pallí, Fanny Turon, Elba Llop, Isabel Cirera, Juan Carlos García-Valdecasas, Virginia Hernández-Gea, Alexandra Flores, Joan Carles García-Pagán
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Background & Aims: Surgery in cirrhosis is associated with a high morbidity and mortality. Retrospectively reported prognostic factors include emergency procedures, liver function (MELD/Child-Pugh scores) and portal hypertension (assessed by indirect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022ba1c004abfaa7e33802089a80296d
http://hdl.handle.net/10230/43589
http://hdl.handle.net/10230/43589
Autor:
Chiara Elia, Giorgio Maria Saracco, Mario Rizzetto, Mauro Bruno, Claudio DeAngelis, Maurizio Fadda, Wilma Debernardi Venon, Alfredo Marzano, Davide Stradella
Publikováno v:
European Journal of Internal Medicine. 25:674-679
Background and objectives Endoscopic variceal ligation (EVL) is recommended to treat esophageal varices (EV) in cirrhosis and portal hypertension. A program of endoscopic surveillance is not clearly established. The aim of this prospective randomized
Publikováno v:
Drugs & Aging. 30:979-986
Mantle cell lymphoma is a distinct subtype of B-cell non-Hodgkin lymphoma, accounting for 3-10 % of all non-Hodgkin lymphoma cases. The median age at diagnosis is nearly 70 years. The prognosis of patients is based on the Mantle Cell Lymphoma Interna
Autor:
Catherine Thieblemont, Marie-Dominique Venon, Jean-Michel Miclea, Lionel Galicier, Pauline Brice, Marie Robin, Josette Brière, David Boutboul, Morgane Cheminant
Publikováno v:
British Journal of Haematology. 158:644-648
Summary The risk of developing Hodgkin lymphoma (HL) is increased in immunodeficiencies or during the treatment of some autoimmune diseases. The development of new therapeutic agents has highlighted the risk of unusual lymphoid proliferations, partic
Autor:
Giorgio Maria Saracco, Emanuela Fagà, D. Reggio, Giovannino Ciccone, Mauro Bruno, Patrizia Carucci, Mario Rizzetto, Mariella De Cento, Chiara Giordanino, C. Barletti, Alessandro Musso, Rinaldo Pellicano, Wilma Debernardi Venon, Claudio De Angelis, Sharmila Fagoonee, Simone Ceretto
Publikováno v:
European journal of gastroenterology & hepatology 24 (2012): 70–76. doi:10.1097/MEG.0b013e32834c16ab
info:cnr-pdr/source/autori:Faga, Emanuela; De Cento, Mariella; Giordanino, Chiara; Barletti, Claudio; Bruno, Mauro; Carucci, Patrizia; De Angelis, Claudio; Venon, Wilma Debernardi; Musso, Alessandro; Reggio, Dario; Fagoonee, Sharmila; Pellicano, Rinaldo; Ceretto, Simone; Ciccone, Giovannino; Rizzetto, Mario; Saracco, Giorgio/titolo:Safety of propofol in cirrhotic patients undergoing colonoscopy and endoscopic retrograde cholangiography: results of a prospective controlled study/doi:10.1097%2FMEG.0b013e32834c16ab/rivista:European journal of gastroenterology & hepatology/anno:2012/pagina_da:70/pagina_a:76/intervallo_pagine:70–76/volume:24
info:cnr-pdr/source/autori:Faga, Emanuela; De Cento, Mariella; Giordanino, Chiara; Barletti, Claudio; Bruno, Mauro; Carucci, Patrizia; De Angelis, Claudio; Venon, Wilma Debernardi; Musso, Alessandro; Reggio, Dario; Fagoonee, Sharmila; Pellicano, Rinaldo; Ceretto, Simone; Ciccone, Giovannino; Rizzetto, Mario; Saracco, Giorgio/titolo:Safety of propofol in cirrhotic patients undergoing colonoscopy and endoscopic retrograde cholangiography: results of a prospective controlled study/doi:10.1097%2FMEG.0b013e32834c16ab/rivista:European journal of gastroenterology & hepatology/anno:2012/pagina_da:70/pagina_a:76/intervallo_pagine:70–76/volume:24
Background and aims: Safety of propofol sedation in patients with liver cirrhosis undergoing colonoscopy or endoscopic retrograde cholangiopancreatography (ERCP) remains to be studied. The aim of this study was to investigate whether the use of propo
Autor:
Flavia Puglisi, S. Caronna, C Sguazzini, Mauro Bruno, Alessandro Musso, Andrea Marengo, Chiara Elia, Mario Rizzetto, Claudio De Angelis, Selene Manfrè, W. Debernardi-Venon
Managing antiplatelet and anticoagulant drugs before endoscopy may be challenging.To assess whether the pre-endoscopic management of antiplatelet/anticoagulant drugs is adherent to current guidelines and the influence of patients' characteristics, re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::142e9740360bfc0ffaf46c7369714ea2
http://hdl.handle.net/2318/154690
http://hdl.handle.net/2318/154690
Autor:
Franco Brunello, Silvia Martini, Wilma Debernardi Venon, Giorgio Maria Saracco, Chiara Elia, Alfredo Marzano, Mario Rizzetto, Davide Stradella
Publikováno v:
European journal of gastroenterologyhepatology. 23(7)
Background Transcatheter arterial chemoembolization (TACE) is a routine treatment for hepatocellular carcinoma in cirrhotic patients. Whether TACE influences the degree of portal hypertension remains uncertain. AIM AND PATIENTS: We retrospectively an
Autor:
Carlo Alessandria, Maurizio Fadda, Mario Rizzetto, Wilma Debernardi Venon, Alfredo Marzano, Silvia Gaia
Publikováno v:
European journal of gastroenterologyhepatology. 16(6)
Background and aims Transjugular intrahepatic portosystemic shunt (TIPS) can manage severe complications of portal hypertension. The Mayo Clinic group proposed a so-called model for end-stage liver disease (MELD) to predict survival in cirrhotic pati
Autor:
Giorgio Maria Saracco, Nicola Leone, M. Rizzetto, E. Rolfo, W. Debernardi Venon, M. Baronio, Maurizio Fadda, C. Barletti, L. Todros
The role of angiotensin II (AT-II) type I receptor antagonists in the treatment of portal hypertension remains controversial. We tested the efficacy of Irbesartan (Irb) vs. Propranolol (Pro) in reducing portal pressure and evaluated its systemic haem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dcb6d8b84e1839842ce6ad18c802ad4
http://hdl.handle.net/2318/38139
http://hdl.handle.net/2318/38139